Last reviewed 2026-04-20 · How we verify

ZEGOCRACTIN

At a glance

Approved indications

No approved indications tracked.

Common side effects

• Hypoglycaemia
• Hyperglycemia
• Anaemia
• Diarrhoea
• Abdominal pain
• Pyrexia
• Hypokalaemia
• Pleural effusion
• Anemia
• Blood Alkaline Phosphatase Increased
• Blood Creatine Phosphokinase Increased
• Hypotension

Key clinical trials

• A Study of Auxora in Patients With Critical COVID-19 Pneumonia (PHASE2)
• A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk" (PHASE2)
• Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase (PHASE1, PHASE2)
• A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS (PHASE2)
• A Study of Auxora in Patients With Severe COVID-19 Pneumonia (PHASE2)
• A Placebo-Controlled Study of Auxora for the Extended Treatment of High- Risk Patients With Critical COVID-19 Pneumonia (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.